Vulvar Disease in Nigeria Observational Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age10-90
SponsorKDRS ltd
About this trial
Vulvar disease in Nigeria A look at awareness within patients and health practitioners, self-reported and actual prevalence within communities in Nigeria
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
biological females - afab
Disqualifiers
none-afab
Trial population
All afab, willing to participate in the study.
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Observation
Other interventionObserving for disease prevalence - actual and self-reported
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Prevalence of Vulvar disease
Awareness of Vulvar disease (descriptor)
Time frame
1-12 months Source ClinicalTrials.gov